ERCC6L2 disease (ED) is an inherited bone marrow failure (BMF) syndrome that progresses almost exclusively to erythroid, TP53-mutated myeloid malignancy, but the somatic evolution underlying the progression in patients is unknown. We characterized the genetic landscape of 29 ED patients with longitudinal sampling, integrating whole-genome and single-cell RNA sequencing, and compared the findings with Shwachman-Diamond syndrome (SDS), another TP53 mutation-prone disease, to define somatic evolution across disease stages. ED was defined by early, intense, and recurrent selection of TP53-mutant c
Intense TP53 pathway selection drives clonal evolution from bone marrow failure to leukemia in ERCC6L2 disease
calendar_today
September 17, 2026
person
Douglas, S. P. M., Kaaja, I., Ikonen, I. I., Langohr, L., Koski, J., Hakkarainen, M., Katainen, L., Barbany, G., Hellstrom-Lindberg, E., Jahnukainen, K., Kakko, S., Siitonen, T., Niinimaki, R., Pitkanen, E., Wartiovaara-Kautto, U., Kilpivaara, O.
domain
medrxiv